Quick Takeaways
- Christopher W. Cain has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Christopher W. Cain
- Location
- Philadelphia, PA
- Signature
- /s/ Garrett Winslow, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christopher W. Cain and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Aerovate Therapeutics, Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Christopher W. Cain
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JBIO | Aerovate Therapeutics, Inc. | Director | 29 Apr 2025 | |||
| COGT | Cogent Biosciences, Inc. | Director | 04 Jun 2025 | |||
| GLTO | Damora Therapeutics, Inc. | Director | 23 Mar 2026 | |||
| VRDN | Viridian Therapeutics, Inc.\DE | Director | 01 Jul 2025 |
Insider Transactions Reported by Christopher W. Cain:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.